Lease or Buy? A Financial Framework for Medical Capital Equipment

The choice between leasing and purchasing a medical device shapes your balance sheet, your technology flexibility, and your operating costs for years — and the wrong structure is hard to unwind.

Why this matters

Picture a community hospital whose 64-slice CT scanner has reached end of service life. The replacement system the radiology director wants is a higher-detector-count platform that — while exact list pricing is not publicly disclosed by most manufacturers and must be negotiated directly — commonly runs well into the high six or low seven figures depending on configuration. The CFO wants to protect the cash reserve earmarked for an emergency department renovation. The radiology director is aware that CT detector technology has been cycling every four to five years and doesn't want to own a system that's clinically obsolete in year six of a ten-year depreciation schedule. The biomedical engineering manager is asking who will hold the service obligation and whether in-house staff can support it. Three people, three legitimate concerns — and each one points toward a different financing structure.

This kind of multi-stakeholder tension is not the exception in healthcare capital planning; it is the rule. Imaging systems, robotic surgical platforms, laboratory analyzers, and dental CBCT units all share the same profile: high acquisition cost, a useful life measured in years, a technology curve that can outpace the financing term, and significant ongoing maintenance costs that rarely appear in the headline monthly payment. Getting the structure right requires modeling those dynamics explicitly, not just comparing lease rates to loan rates on a whiteboard.

What makes this genuinely difficult is that neither option is universally superior. Each one transfers risk — obsolescence risk, capital risk, maintenance risk, residual-value risk — to a different party. The strategic question is which party is better positioned to absorb each type of risk, and whether the price of that transfer is fair.

The decisions that shape the outcome

Lease classification affects your balance sheet more than you may expect

Before 2019, health systems frequently used operating leases because they kept the associated liability off the balance sheet. FASB Accounting Standards Codification Topic 842 (ASC 842) closed much of that optionality: most leases longer than 12 months now require the lessee to record a right-of-use asset and a corresponding lease liability, regardless of operating-versus-finance classification. Finance leases (formerly called capital leases) go further still, front-loading interest expense and depreciation in a way that can compress reported margins in early periods. For not-for-profit health systems with bond covenants tied to debt ratios, the classification of a single large equipment lease can have downstream consequences that were never discussed during equipment selection. Involve your auditor in the deal structure before you negotiate term length, not after.

Monthly payment and total cost of ownership are different numbers

A lease agreement on a high-field MRI might quote an attractive monthly figure while excluding helium fills, coil replacements, software upgrade fees, and the comprehensive service contract that keeps the system within its IEC 60601-1 performance specifications. Ownership, by contrast, allows you to amortize the asset over its rated useful life and to competitively tender service coverage at each renewal cycle. Total cost of ownership over a 10-year horizon — encompassing acquisition, maintenance, consumables, training, and eventual disposition — can differ substantially between a purchase and a lease for the same device, though the direction and magnitude depend heavily on negotiated contract terms. Run the full NPV model at your organization's weighted average cost of capital. If your finance team is only comparing monthly payments, the model is incomplete.

Technology obsolescence is real — but it doesn't apply equally to every device category

The standard leasing pitch is that you return the equipment at term end and upgrade to the new platform. This is a legitimate argument for modalities where clinical capability advances rapidly: interventional imaging, genomics analyzers, robotic surgery systems where software-driven feature sets evolve annually. It is a much weaker argument for capital infrastructure that changes slowly — patient monitoring systems, dental chairs, infusion pump fleets, basic ultrasound in stable clinical settings. Paying a financing premium for obsolescence protection you don't need is a real cost. Before accepting "lease to stay current" as a universal principle, assess the actual technology refresh cycle for the specific device class in question.

Service and consumable terms can quietly reprice the deal

Many lease structures bundle a full-service contract into the monthly payment. This looks clean until you realize the bundled rate is higher than what competitive bidding would produce, or that reagent and consumable exclusivity clauses — common in laboratory equipment